M16.2
Bilateral osteoarthritis resulting from hip dysplasia
Clinical Classification Guidelines
Medical Intelligence & Overview
Bilateral osteoarthritis resulting from hip dysplasia (ICD-10 code M16.2) is a condition characterized by the degeneration of joint cartilage in both hips due to developmental issues. Hip dysplasia refers to an abnormal formation of the hip joint, which can lead to uneven wear and tear over time. This condition often impacts mobility and quality of life, especially as symptoms progress. Recognizing the causes, symptoms, and potential treatment options can help individuals manage the condition effectively.
Causes & Symptoms
Clinical Causes: Developmental abnormalities in the hip joint present from birth (congenital hip dysplasia). Genetic predisposition affecting connective tissue and joint development. Biological factors leading to improper formation of the hip socket and femoral head. Environmental influences such as lack of proper prenatal care or trauma during early childhood. Progression of untreated or inadequately managed hip dysplasia resulting in joint degeneration.
Key Symptoms: Persistent pain in the hips, especially after activity or standing for long periods. Stiffness and limited range of motion in the hips. A grinding or clicking sensation during movement. Muscle weakness around the hips. Visible deformities or asymmetry in the hips or legs. Difficulty walking or performing routine activities due to joint discomfort. Swelling or tenderness around the hip joints in advanced cases.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of physical examinations and imaging studies. Healthcare providers assess joint mobility, pain levels, and physical appearance. Imaging techniques such as X-rays are essential to visualize joint degeneration, assess the severity of osteoarthritis, and confirm the presence of bilateral involvement. In some cases, MRI scans may be utilized for detailed soft tissue evaluation. The diagnosis also considers a person's medical history, particularly the presence and severity of congenital hip dysplasia.
Treatment Protocols: Managing bilateral osteoarthritis caused by hip dysplasia focuses on alleviating symptoms and improving joint function. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is M16.2 a billable ICD-10 code?
Yes, M16.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M16.2?
Clinical documentation must specify the nature of Bilateral osteoarthritis resulting from hip dysplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference